BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fang Z, Tang Y, Ying J, Tang C, Wang Q. Traditional Chinese medicine for anti-Alzheimer's disease: berberine and evodiamine from Evodia rutaecarpa. Chin Med 2020;15:82. [PMID: 32774447 DOI: 10.1186/s13020-020-00359-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Han J, Zhang H, Zhang Y, Zhang Z, Yu M, Wang S, Han F. Lingguizhugan decoction protects PC12 cells against Aβ25-35-induced oxidative stress and neuroinflammation by modulating NF-κB/MAPK signaling pathways. J Ethnopharmacol 2022;292:115194. [PMID: 35304276 DOI: 10.1016/j.jep.2022.115194] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
2 Rao Z, Zeng J, Li X, Peng L, Wang B, Luan F, Zeng N. JFNE-A isolated from Jing-Fang n-butanol extract attenuates lipopolysaccharide-induced acute lung injury by inhibiting oxidative stress and the NF-κB signaling pathway via promotion of autophagy. Phytomedicine 2021;96:153891. [PMID: 35026506 DOI: 10.1016/j.phymed.2021.153891] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Cheng H, Liu J, Tan Y, Feng W, Peng C. Interactions between gut microbiota and berberine, a necessary procedure to understand the mechanisms of berberine. Journal of Pharmaceutical Analysis 2021. [DOI: 10.1016/j.jpha.2021.10.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
4 Londzin P, Kocik S, Kisiel-nawrot E, Janas A, Skoczyńska A, Krivošíková Z, Štefíková K, Gajdoš M, Cegieła U, Folwarczna J. Lack of berberine effect on bone mechanical properties in rats with experimentally induced diabetes. Biomedicine & Pharmacotherapy 2022;146:112562. [DOI: 10.1016/j.biopha.2021.112562] [Reference Citation Analysis]
5 Tang C, Fang Z, Chu D, Zhang L, Tang Y, Zhou J, Fang R, Ying J, Wang F, Zhou Y, Xu C, Wang Q. Pharmacodynamics, Network Pharmacology, and Pharmacokinetics of Chinese Medicine Formula 9002A in the Treatment of Alzheimer’s Disease. Front Pharmacol 2022;13:849994. [DOI: 10.3389/fphar.2022.849994] [Reference Citation Analysis]
6 Ibrahim Fouad G, Ahmed KA. The protective impact of berberine against doxorubicin-induced nephrotoxicity in rats. Tissue Cell 2021;73:101612. [PMID: 34371291 DOI: 10.1016/j.tice.2021.101612] [Reference Citation Analysis]
7 Majidazar R, Rezazadeh-Gavgani E, Sadigh-Eteghad S, Naseri A. Pharmacotherapy of Alzheimer's disease: an overview of systematic reviews. Eur J Clin Pharmacol 2022. [PMID: 35881170 DOI: 10.1007/s00228-022-03363-6] [Reference Citation Analysis]
8 Gaba S, Saini A, Singh G, Monga V. An insight into the medicinal attributes of berberine derivatives: A review. Bioorg Med Chem 2021;38:116143. [PMID: 33848698 DOI: 10.1016/j.bmc.2021.116143] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
9 Zhang X, Lin L, Li H, Xia W, Liu Q, Zhou X, Dong L, Fu X. Update on new trend and progress of the mechanism of polysaccharides in the intervention of Alzheimer's disease, based on the new understanding of relevant theories: A review. Int J Biol Macromol 2022;218:720-38. [PMID: 35902016 DOI: 10.1016/j.ijbiomac.2022.07.158] [Reference Citation Analysis]
10 Wang F, Chen H, Hu Y, Chen L, Liu Y. Integrated comparative metabolomics and network pharmacology approach to uncover the key active ingredients of Polygonati rhizoma and their therapeutic potential for the treatment of Alzheimer’s disease. Front Pharmacol 2022;13:934947. [DOI: 10.3389/fphar.2022.934947] [Reference Citation Analysis]